A0A6D2WD68 (A0A6D2WD68_PONAB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)
Gamma-aminobutyric acid receptor subunit alpha-1 UniProtKBInterProInteractive Modelling
Available Structures
31 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with bicuculline and m… |
Heteromer P14867; P18507; P28472; | 100.0 | 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×H0Z; 2×PIO; | |||
| CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with GABA and puerarin |
Heteromer P14867; P18507; P28472; | 100.0 | 1×NAG; 3×NAG; 2×NAG; 2×PGW; 11×D10; 10×HEX; 2×PT5; 5×R16; 3×PLM; 3×CL; 2×ABU; 1×NAG; 1×A1H6W; 1×PX2; | |||
| Complex of GABA-A synaptic receptor with autoimmune antibody Fab175 |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 2×NAG; 1×NAG; 2×ABU; 2×NAG; 1×MAN; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 6×PTY; 1×Q3G; 1×A8W; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus PPTQ |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 3×NAG; 1×NAG; 2×ABU; 2×A1ADN; 5×PTY; 1×POV; 2×Q3G; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus methaqualone |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 3×NAG; 1×NAG; 2×ABU; 3×A1ADG; 4×PTY; 2×Q3G; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus etomidate |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 2×V8D; | |||
| Cryo-EM structure of the human synaptic alpha1-beta3-gamma2 GABAA receptor in complex with Megabody… |
Heteromer P14867; P18507; P28472; | 100.0 | 2×NAG; 3×NAG; 1×NAG; 1×NAG; 3×POV; 2×PIO; | |||
| Complex of GABA-A synaptic receptor with autoimmune antibody Fab115 |
Heteromer P14867; P18507; P47870; | 100 | 4×NAG; 2×NAG; 1×NAG; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone s… |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 1×ZWY; 6×PTY; 1×Q3G; 1×POV; | |||
| CryoEM structure of human full-length heteromeric alpha1beta3gamma2L GABA(A)R in complex with picro… |
Heteromer P14867; P18507; P28472; | 100.0 | 1×NAG; 2×NAG; 3×NAG; 1×NAG; 2×PIO; 1×RI5; 2×ABU; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 2×PFL; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus picrotoxin |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 1×RI5; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus diazepam |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 4×DZP; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide |
Heteromer P14867; P18507; P47870; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×J94; 1×MAN; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA |
Heteromer P14867; P18507; P47870; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus phenobarbital |
Heteromer P14867; P18507; P47870; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 2×UQA; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus flumazenil |
Heteromer P14867; P18507; P47870; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 1×FYP; | |||
| Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation… |
Heteromer P14867; P18507; P47870; | 100 | 2×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 12×Y01; 1×FYP; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×Y4B; 2×ABU; | |||
| Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation… |
Heteromer P14867; P18507; P47870; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 12×Y01; 1×FYP; | |||
| GABA-A receptor bound by a-Cobratoxin |
Heteromer P01391; P14867; P28472; | 100 | 1×NAG; 1×NAG; 1×NAG; 1×NAG; 4×NAG; 1×HSM; 1×ZN; 1×HEX; | |||
| Cryo-EM structure of human full-length synaptic alpha1beta3gamma2 GABA(A)R in complex with Ro15-451… |
Heteromer P14867; P18507; P28472; | 100.0 | 1×NAG; 2×NAG; 2×NAG; 1×NAG; 2×PIO; 1×OCT; 4×D10; 3×CL; 1×NAG; 1×EIE; | |||
| a1b3 GABA-A receptor + GABA |
Heteromer P14867; P28472; | 100 | 2×NAG; 3×NAG; 2×ABU; 3×NAG; 1×HSM; | |||
| a1b3 GABA-A receptor + GABA + Zn2+ |
Heteromer P14867; P28472; | 100 | 3×NAG; 1×NAG; 2×NAG; 2×NAG; 2×UND; 2×OCT; 4×HEX; 2×ABU; 1×ZN; 1×HSM; 3×D10; | |||
| CryoEM structure of human full-length heteromeric alpha1beta3gamma2L GABA(A)R in complex with alpra… |
Heteromer P14867; P18507; P28472; | 100.0 | 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×ABU; 2×PIO; 1×08H; | |||
| CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with diazepam (Valium)… |
Heteromer P14867; P18507; P28472; | 100.0 | 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×PIO; 2×ABU; 3×DZP; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus DMCM |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 3×R63; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus Zolpidem |
Heteromer P14867; P18507; P47870; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 3×R5R; 2×ABU; | |||
| Crystal structure of an apo chimeric human alpha1GABAA receptor | homo-5-mer | 100 | ||||
| Crystal structure of a chimeric human alpha1GABAA receptor in complex with alphaxalone | homo-5-mer | 100 | 5×EY4; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8foi.1.C | monomer | 0.73 | 1×PIO; 1×D12; 2×OCT; | 98.68 | ||